FDA
-
-
-
-
-
-
-
RenovaCare Responds to SEC Complaint
-
-
-
-
-
-
-
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
-
-
-
-
-
-
-
Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Board Secretary
-
-
-
-
-
-
-
Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare
-
-
-
-
-
-
-
Vice President to Expand RenovaCare SkinGun™ Technology for New Medical Conditions Beyond Burns
-
-
-
-
-
-
-
RenovaCare Announces Successful FDA Meeting
-
-
-
-
-
-
-
Outcomes of Burn Patients Treated with Cell Spray Technology Behind RenovaCare SkinGun™ Published in Prestigious Medical Journal
324,800 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

